首页> 外国专利> PHARMACEUTICAL PREPARATION FOR ORAL ADMINISTRATION CONTAINING SUSTAINED-RELEASE GRANULES CONTAINING HYDROCHLORIDE SALT OF TAMSULOSIN

PHARMACEUTICAL PREPARATION FOR ORAL ADMINISTRATION CONTAINING SUSTAINED-RELEASE GRANULES CONTAINING HYDROCHLORIDE SALT OF TAMSULOSIN

机译:包含他莫昔洛酮盐酸盐的缓释颗粒口服制剂的药物制备

摘要

The present invention relates to a pharmaceutical preparation for oral administration, containing sustained-release granules containing hydrochloride salt of tamsulosin. More specifically, provided are a pharmaceutical preparation for oral administration, and a production method thereof. The sustained-release granule consists of: 10-300 parts by weight of polyvinyl acetate; 5-250 parts by weight of hydroxy propyl methyl cellulose; and 1-450 parts by weight of a diluent, with respect to 1 parts by weight of the hydrochloride salt of tamsulosin. The weight ratio of the sustained-release granule is 360-495 parts by weight with respect to 1 parts by weight of the hydrochloride salt of tamsulosin.;COPYRIGHT KIPO 2017
机译:本发明涉及用于口服给药的药物制剂,其包含含有坦洛新盐酸盐的缓释颗粒。更具体地,提供了用于口服给药的药物制剂及其生产方法。该缓释颗粒由:10-300重量份的聚乙酸乙烯酯;和5-250重量份的羟丙基甲基纤维素;相对于1重量份坦洛新的盐酸盐,稀释剂为1-450重量份。相对于1重量份的坦洛新盐酸盐,缓释颗粒的重量比为360-495重量份。; COPYRIGHT KIPO 2017

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号